City Therapeutics, Inc. share price logo

City Therapeutics, Inc.

NYSE: CTY

Live

as on

City Therapeutics, Inc. Stock Performance

as on January 1, 1970 at 11:00 am IST

City Therapeutics, Inc. share price movements today

Previous Close
-
Open
-
Volume
-

City Therapeutics, Inc. Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

City Therapeutics, Inc. Stock Fundamentals & Key Indicators

Check City Therapeutics, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

PEG Ratio

0.00

Return On Equity TTM

0.00%

City Therapeutics, Inc. stock Key Stats

Compare market cap, revenue, PE, and other key metrics of City Therapeutics, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$-NANA0.00%0.00%

City Therapeutics, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Jun 2018
Sep 2018
Dec 2018
Mar 2019
Jun 2019
Sep 2019
Dec 2019
Mar 2020
Jun 2020
Sep 2020
Total Revenue
2,101
2,149
2,113
2,055
2,051
2,039
2,012
1,918
524
1,801
Gross Profit
2,101
2,149
2,113
1,448
1,463
1,409
-1,238
1,445
1,145
1,273
Operating Income
626
717
685
760
750
748
626
779
679
617
EBITDA
-
-
-
-
-
-
-
-
-
-
Interest Expense
134
127
113
111
111
110
110
91
91
87
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
508
564
577
658
644
643
523
680
583
512
Income Tax Expense
81
111
172
171
167
166
137
177
153
133
Net Income
427
453
405
487
477
477
386
503
430
379
Net Profit Margin
20.32%
21.08%
19.17%
23.70%
23.26%
23.39%
19.18%
26.23%
82.06%
21.04%

City Therapeutics, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2012
Dec 2013
Dec 2014
Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Total Revenue
8,848
8,753
8,838
8,964
8,910
8,550
8,493
8,157
Gross Profit
-
8,753
8,838
8,964
8,910
8,550
8,493
4,907
Operating Income
1,905
2,078
2,112
2,260
2,322
2,313
2,660
2,884
EBITDA
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
Income Before Tax
-
1,566
1,609
1,733
1,763
1,791
2,159
2,468
Income Tax Expense
542
602
639
659
678
134
494
641
Net Income
-
964
970
1,074
1,085
1,657
1,665
1,827
Net Profit Margin
0.00%
11.01%
10.98%
11.98%
12.18%
19.38%
19.60%
22.40%

City Therapeutics, Inc. Quarterly Cash Flow

All numbers in Millions USD

Sep 2018
Dec 2018
Mar 2019
Jun 2019
Sep 2019
Dec 2019
Mar 2020
Jun 2020
Sep 2020
Net Income
1,260
1,665
487
964
1,441
1,827
503
933
1,312
Operating Cash Flow
901
1,139
732
1,505
2,317
1,015
785
699
2,251
Investing Cash Flow
791
-786
-375
-797
-1,209
-514
830
-75
959
Financing Cash Flow
-1,697
-354
-353
-706
-1,110
-502
-1,609
-627
-3,206
Change in Cash
-5
-1
4
2
-2
-1
6
-3
4

City Therapeutics, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2013
Dec 2014
Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Net Income
964
970
1,074
1,085
1,657
1,665
1,827
Operating Cash Flow
2,713
2,801
2,591
2,652
2,435
3,791
3,332
Investing Cash Flow
-1,381
-1,251
-1,220
-1,334
-1,436
-1,153
-1,723
Financing Cash Flow
-1,326
-1,558
-1,374
-1,316
-1,003
-2,634
-1,612
Change in Cash
6
-8
-3
2
-4
4
-3

About City Therapeutics, Inc.

Qwest Corporation, an integrated communications company, provides communications services to business and residential customers in Arizona, Colorado, Idaho, Iowa, Minnesota, Montana, Nebraska, New Mexico, North Dakota, Oregon, South Dakota, Utah, Washington, and Wyoming. It offers broadband services that allow customers to connect to Internet through existing telephone lines or fiber-optic cables; Ethernet services, including point-to-point and multi-point equipment configurations that facilitate data transmissions in metropolitan areas and wide area networks, as well as to provide transmission services to wireless service providers; and satellite television services under the DIRECTV brand name. The company also provides local voice services, such as call forwarding, caller identification, conference calling, voice mail, selective call ringing, and call waiting, as well as resale of voice services and the sale of unbundled network elements; switched access services to wireline and wireless service providers for the use of its facilities to originate and terminate their interstate and intrastate voice transmissions; integrated services digital network services; wide area network that enables local communications network to link to networks in remote locations; private line services for directly connecting two or more sites; and information technology services. As of December 31, 2017, it operated approximately 6.1 million access lines; and served approximately 3.3 million broadband subscribers. The company was incorporated in 1911 and is based in Monroe, Louisiana. Qwest Corporation operates as a subsidiary of CenturyLink, Inc.
OrganisationCity Therapeutics, Inc.
IndustryOther

FAQs

How to invest in City Therapeutics, Inc. Stock (CTY) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for City Therapeutics, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy City Therapeutics, Inc. Stock (CTY) from India?

Indian investors can start investing in City Therapeutics, Inc. (CTY) shares with as little as ₹95.2699966430664 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.70 in City Therapeutics, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Learn more about fractional shares .